Sage Journals: Discover world-class research

Free access

Research article

First published 2011-4

The impact of LABA+ICS fixed combinations on morbidity and economic burden of COPD in Italy: a six-year observational study

Roberto Dal Negro, Luca Bonadiman, Silvia Tognella [...]

Therapeutic Advances in Respiratory Disease

Retricted access

Research article

First published 2017-11

Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β 2 -Agonist Combined With a Long-Acting Muscarinic or Inhaled Corticosteroid

Jennifer C. Samp, Min J. Joo, Glen T. Schumock [...]

Annals of Pharmacotherapy

Free access

Review article

First published 2008-10

Review: Differences in the pharmacodynamics of budesonide/formoterol and salmeterol/fluticasone reflect differences in their therapeutic usefulness in asthma

Bertil Lindmark

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2022

Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolution

Fulvio Braido, Angelo G. Corsico, Davide Paleari [...]

Therapeutic Advances in Respiratory Disease

Free access

Other

First published 2009-04

Clinical and pharmacoeconomic profile of COPD patients with FEV1 50—60% predicted: pilot study on the impact of the extended indication of ICS/LABA

Roberto Walter Dal Negro, Luca Bonadiman, Claudio Turati [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2018

Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate,umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects

Mario Malerba, Matteo Nardin, Giuseppe Santini [...]

Therapeutic Advances in Respiratory Disease

Retricted access

Research article

First published 2016-08

Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations

Alberto Papi, Adel H. Mansur, Tetyana Pertseva [...]

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Retricted access

Review article

First published 2012-08

Introduction to the Canadian Scientific Advisory Committee on Respiratory and Allergy Therapies: In Vivo Evaluation For Clinical Testing in COPD and Asthma Therapy Using Generics

Irvin Mayers

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Open access

Research article

First published 2020

Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACT

José M. Marín, Luis Mateos, Juan Roldán [...]

Therapeutic Advances in Respiratory Disease

Search results